Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
When do you consider switching a generic formulation antiseizure medication to the brand formulation?
Related Questions
When do you consider vigabatrin for the treatment of status epilepticus?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
When do you attribute tremors to lamotrigine?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
What are the most significant drug interactions you consider when using cenobamate and would you ever consider using cenobamate as monotherapy?
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
Does valproic acid or lithium use in the egg donor pose a risk to the fetus in a surrogate pregnancy?
When would you start antiseizure medications in tuberous sclerosis before onset of seizures?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
What prompts you to consider prescribing different formulations of benzodiazepines for a seizure rescue medication?
